Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies—A Real-World Analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancers 15 (2023) 20, 4966, 1-12
- Event
-
Veröffentlichung
- (where)
-
Münster
- (who)
-
Universitäts- und Landesbibliothek Münster
- (when)
-
2024
- Creator
-
Lange, Stefan Andreas
Schliemann, Christoph
Engelbertz, Christiane Maria
Feld, Jannik
Makowski, Lena-Maria
Gerß, Joachim
Dröge, Patrik
Ruhnke, Thomas
Günster, Christian
Reinecke, Holger
Köppe, Jeanette
- DOI
-
10.17879/47978470488
- URN
-
urn:nbn:de:hbz:6-37978481163
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lange, Stefan Andreas
- Schliemann, Christoph
- Engelbertz, Christiane Maria
- Feld, Jannik
- Makowski, Lena-Maria
- Gerß, Joachim
- Dröge, Patrik
- Ruhnke, Thomas
- Günster, Christian
- Reinecke, Holger
- Köppe, Jeanette
- Universitäts- und Landesbibliothek Münster
Time of origin
- 2024
Other Objects (12)
Acute coronary syndrome : antithrombotic therapy and secondary prevention
Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis
Identification of acute coronary syndrome via body-surface mapping and inverse electrocardiography
Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Hematologic malignancies : acute leukemias ; with 51 tables
Commentary on hostility and physiological responses to laboratory stress in acute coronary syndrome patients
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES Trial
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial
The effect of hypoxia on exercise tolerance in persons after acute coronary syndrome treated with angioplasty combined with coronary stent implantation : pilot studies
Acute coronary syndrome : antithrombotic therapy and secondary prevention
Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis
Identification of acute coronary syndrome via body-surface mapping and inverse electrocardiography
Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Hematologic malignancies : acute leukemias ; with 51 tables
Commentary on hostility and physiological responses to laboratory stress in acute coronary syndrome patients
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES Trial
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial
The effect of hypoxia on exercise tolerance in persons after acute coronary syndrome treated with angioplasty combined with coronary stent implantation : pilot studies
Acute coronary syndrome : antithrombotic therapy and secondary prevention
Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis
Identification of acute coronary syndrome via body-surface mapping and inverse electrocardiography
Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome
Hematologic malignancies : acute leukemias ; with 51 tables
Commentary on hostility and physiological responses to laboratory stress in acute coronary syndrome patients
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES Trial
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial